Syndax Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87164F1057

SecuritySNDX / Syndax Pharmaceuticals, Inc.
InstitutionGhost Tree Capital, LLC
Latest Disclosed Ownership450,000 shares
Latest Disclosed Value $ 8,662,500
Ghost Tree Capital, LLC ownership in SNDX / Syndax Pharmaceuticals, Inc.

On November 14, 2024 - Ghost Tree Capital, LLC filed a 13F-HR form disclosing ownership of 450,000 shares of Syndax Pharmaceuticals, Inc. (US:SNDX) valued at $8,662,500 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 350,000 shares of Syndax Pharmaceuticals, Inc.. This represents a change in shares of 28.57% during the quarter. The current value of the position is $7,794,000 USD.

Ghost Tree Capital, LLC has a history of taking positions in derivatives of the underlying security (SNDX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SNDX / Syndax Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 450,000 100,000 28.57 8,662 20.56 2.6167
2024-08-14 2024-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 350,000 200,000 133.33 7,186 101.26 2.2501
2024-05-15 2024-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 150,000 150,000 3,570 0.9881
2024-02-14 2023-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 0 -200,000 -100.00 0 -100.00
2023-11-14 2023-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 200,000 -150,000 -42.86 2,904 -60.35 0.9551
2023-08-14 2023-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 350,000 25,000 7.69 7,326 6.72 2.4183
2023-05-15 2023-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 325,000 175,000 116.67 6,864 79.78 2.0288
2023-02-14 2022-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 150,000 -50,000 -25.00 3,818 -20.56 1.6301
2022-11-14 2022-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 200,000 -25,000 -11.11 4,806 11.02 1.3490
2022-08-15 2022-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 225,000 0 0.00 4,329 10.69 2.2548
2022-05-16 2022-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 225,000 -75,000 -25.00 3,911 -40.44 0.8487
2022-02-16 2021-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 300,000 -275,000 -47.83 6,567 -40.23 2.3534
2021-11-15 2021-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 575,000 -300,000 -34.29 10,988 -26.86 3.2130
2021-08-11 2021-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 875,000 -300,000 -25.53 15,024 -42.82 4.1299
2021-08-11 2021-03-31 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 1,175,000 -175,000 -12.96 26,273 -12.49 6.1750
2021-05-14 2021-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 1,175,000 -175,000 26,273 6.1750
2021-02-18 2020-12-31 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 1,350,000 925,000 217.65 30,024 378.62 6.6902
2021-02-16 2020-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 1,350,000 925,000 30,024 6,530,392.0758
2020-11-16 2020-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 425,000 240,000 129.73 6,273 128.77 1.8131
2020-08-14 2020-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 185,000 -65,000 -26.00 2,742 -0.04 0.7234
2020-05-15 2020-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 250,000 250,000 2,743 0.7275
2017-11-14 2017-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 0 -200,000 -100.00 0 -100.00
2017-08-14 2017-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 200,000 200,000 2,794 0.5808
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F SYNDAX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F SYNDAX PHARMACEUTICALS COM Put 300,000 4,356 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.